N. Espínola, “Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina”, Rev Peru Med Exp Salud Publica, vol. 41, no. 2, pp. 129–38, Jun. 2024, doi: 10.17843/rpmesp.2024.412.12934.